Terrance P. Coyne, EVP & CFO: Royalty Pharma RPRX Sell · Filed 25/11/19

Trade details

Type: Insider sale
Amount: $2,587,669.2
Shares · price: 65,844 sh · $39.30 a share
Held after: 724,156 sh
Stock: Royalty Pharma RPRX
Person: Terrance P. CoyneEVP & CFO
Trade date: 25/11/17
Filed: 25/11/19
Days to filing: 2 days

Sold 8.3% of holdings

Share of holding sold: 8.3%

Royalty Pharma trades, last 26 weeks

What else happened in Royalty Pharma around then

Filed or reported within 30 days of the trade day · 25/10/18~25/12/17

Terrance P. Coyne's recent trades

Terrance P. CoyneEVP & CFO
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$644.3K
11,002 sh
$644.3K
Filed 08/13
Traded 08/13
Terrance P. CoyneEVP & CFO
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$3.5M
64,399 sh
$3.5M
Filed 05/28
Traded 05/26
Terrance P. CoyneEVP & CFO
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$3.5M
64,399 sh
$3.5M
Filed 05/26
Traded 05/26
Terrance P. CoyneEVP & CFO
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$1.6M
32,916 sh
$1.6M
Filed 04/30
Traded 04/28
Terrance P. CoyneEVP & CFO
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$93.3K
1,875 sh
$93.3K
Filed 04/30
Traded 04/28

Terrance P. Coyne, CFO — sold $2.6M of Royalty Pharma RPRX · 8.3% of holdings · 10b5-1 plan | Whalegun